AlvinLReavesMD

Internal Medicine • Orangeburg, SC

Hospice & Palliative Medicine, Hospital Medicine/Hospitalist

Physician

Join to view full profile

Are you Dr. Reaves?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 58 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3000 Saint Matthews Rd
Orangeburg, SC 29118
Phone+1 803-395-2200

Fax+1 803-395-2237
Is this information wrong?

Summary

Dr. Alvin Reaves, MD is a board certified internist in Orangeburg, South Carolina. He is currently licensed to practice medicine in South Carolina, Maryland, and Georgia. He is affiliated with MedStar Southern Maryland Hospital Center and Adventist Healthcare Shady Grove Medical Center.

Education & Training

Clinical Center at the National Institutes of HealthFellowship, Hospice and Palliative Medicine, 2010 - 2011
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1998 - 2002
Virginia Commonwealth University School of MedicineClass of 1998

Certifications & Licensure

MD State Medical License 2017 - 2025
SC State Medical License 2003 - 2025
VA State Medical License 2010 - 2024
DC State Medical License 2001 - 2024
GA State Medical License 2011 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine

Publications & Presentations

PubMed

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinic...
Bressler, N. M., Bressler, S. B., Haynes, L. A., Hao, Y., Kaiser, P. K., Miller, J. W., Naor, J., Potter, M. J., Pournaras, C. J., Reaves, A., Rosenfeld, P. J., Schmid...> ;Arch Ophthalmol. 2005 Sep
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab, M., Boyer, D. S., Bressler, N. M., Bressler, S. B., Cihelkova, I., Hao, Y., Immonen, I., Lim, J. I., Menchini, U., Naor, J., Potter, M. J., Reaves, A., Rosenfeld...> ;Arch Ophthalmol. 2005 Apr
Verteporfin in Photodynamic Therapy: report no. 5.
Bandello, F., Blinder, K., Bressler, N. M., Brown, A. L., Miller, J. W., Potter, M. J., Pournaras, C., Reaves, A., Rosenfeld, P. J., Slakter, J. S., Soubrane, G., Stro...> ;Ophthalmology. 2004 Nov
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical ...
Azab, M., Benchaboune, M., Blinder, K. J., Bressler, N. M., Bressler, S. B., Gragoudas, E. S., Fish, G. E., Hao, Y., Haynes, L., Lim, J. I., Menchini, U., Miller, J. W...> ;Retina (Philadelphia, Pa). 2004 Feb
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
Arnold, J. J., Blinder, K. J., Bressler, N. M., Bressler, S. B., Burdan, A., Haynes, L., Lim, J. I., Miller, J. W., Potter, M. J., Reaves, A., Rosenfeld, P. J., Sicken...> ;Am J Ophthalmol. 2004 Apr
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to...
Blinder, K. J., Bradley, S., Bressler, N. M., Bressler, S. B., Donati, G., Hao, Y., Ma, C., Menchini, U., Miller, J., Potter, M. J., Pournaras, C., Reaves, A., Rosenfe...> ;Am J Ophthalmol. 2003 Sep
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report N...
Barbazetto, I., Burdan, A., Bressler, N. M., Bressler, S. B., Haynes, L., Kapetanios, A. D., Lukas, J., Olsen, K., Potter, M., Reaves, A., Rosenfeld, P., Schachat, A. ...> ;Arch Ophthalmol. 2003 Sep
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Blinder, K. J., Blumenkranz, M. S., Bressler, N. M., Bressler, S. B., Donato, G., Lewis, H., Lim, J. I., Menchini, U., Miller, J. W., Mones, J. M., Potter, M. J., Pour...> ;Ophthalmology. 2003 Apr
Improvement after verteporfin therapy.
Anand, R., Bressler, N. M., Bressler, S. B., Gray, T. E., Harvey, P., Haynes, L., Koester, J. M., Manos, K. S., Miller, J. W., Murphy, S., Reaves, A., Sickenberg, M., ...> ;Arch Ophthalmol. 2003 Mar
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion compo...
Bressler, N. M., Arnold, J., Benchaboune, M., Blumenkranz, M. S., Fish, G. E., Gragoudas, E. S., Lewis, H., Schmidt-Erfurth, U., Slakter, J. S., Bressler, S. B., Manos...> ;Arch Ophthalmol. 2002 Nov
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clini...
Blumenkranz, M. S., Bressler, N. M., Bressler, S. B., Donati, G., Fish, G. E., Haynes, L. A., Lewis, H., Miller, J. W., Monés, J. M., Potter, M. J., Pournaras, C., Rea...> ;Arch Ophthalmol. 2002 Oct
Join now to see all

Hospital Affiliations

MedStar Southern Maryland Hospital CenterClinton, Maryland
Adventist Healthcare Shady Grove Medical CenterRockville, Maryland